Media/Policy Watch
This section is intended to alert readers to substantive news, analysis and opinion from the general media on vaccines, immunization, global; public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.

We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

.

Associated Press
http://hosted.ap.org/dynamic/fronts/HOME?SITE=AP&SECTION=HOME
Glaxo recalls flu vaccine due to potency problem
By MATTHEW PERRONE
AP Health Writer
WASHINGTON (AP) — GlaxoSmithKline is recalling remaining doses of a popular four-in-one flu vaccine because of effectiveness problems.
The company alerted U.S. customers Tuesday that the vaccine can lose potency over time and fail to adequately protect against some strains of the flu. The Flulaval Quadrivalent Thimerosal-free vaccine in prefilled syringes is designed to protect against four strains of influenza virus…

.

Financial Times
http://www.ft.com/hme/uk
Accessed 25 April 2015
Fight intensifies against malaria
23 April 2015
This will be a decisive year for malaria. From the jungles of the Greater Mekong or the urban shanties of Haiti, new tools and tactics are being used to counter the spread of the disease and to alleviate its huge economic and human costs.
It still infects 200m people each year and kills nearly 600,000, yet enormous progress has been made since the start of the millennium — the death rate has halved and an estimated 4.3m lives have been saved but there are concerns over funding and biological resistance…

.

Washington Post
http://www.washingtonpost.com/
Accessed 25 April 2015
With bird flu spreading, USDA starts on potential vaccine
The U.S. Department of Agriculture is working on a vaccine to counter a deadly strain of bird flu, as losses to poultry producers mount.
Steve Karnowski | AP | Energy & Environment | Apr 22, 2015
CDC eyeing bird flu vaccine for humans, though risk is low
Federal officials say they’re taking steps to create a human vaccine for the bird flu virus that’s affected the Midwest poultry industry, though they still consider the danger to be low.
Steve Karnowski | AP | Business | Apr 22, 2015